Antitachycardia pacing and low-energy cardioversion for ventricular tachycardia termination: a clinical perspective.
When incorporated into tiered therapy implantable cardioverter defibrillators (ICDs), antitachycardia pacing (ATP) techniques have proved useful for termination of sustained monomorphic ventricular tachycardias (VT) and have the advantages of rapid delivery, absence of patient discomfort, and minimal battery drain. The efficacy of low-energy cardioversion (LEC) is similar to that of pacing techniques for VT termination, but LEC has the disadvantages of patient discomfort, atrial proarrhythmia, and greater battery drain compared with ATP. Acceleration of VT occurs with similar frequency with each technique. Neither technique should be used without back-up defibrillation capability in an ICD. VT termination algorithms are currently empiric and require repetitive arrhythmia induction and trials of ATP or LEC. Future studies of the risk and benefits of each technique are likely to define optimal programming strategies in tiered therapy ICDs.
Estes
N A
NA
Cardiac Arrhythmia Service, New England Medical Center Hospital, Boston, MA 02111.
Haugh
C J
CJ
Wang
P J
PJ
Manolis
A S
AS
D000465:Algorithms; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D017147:Defibrillators, Implantable; D004554:Electric Countershock / Q000379:methods*; D004562:Electrocardiography; D004867:Equipment Design; D006801:Humans; D010138:Pacemaker, Artificial; D017180:Tachycardia, Ventricular / Q000628:therapy*